$450.00+1.42%Close 13 Nov 2026 · Market value $55.10B
In its results release of 6 Nov 2026 (Q3 FY2026), Humana gave 2 forecasts in figures, among them EPS (gaap) of $16.84 for FY2026.
Read from the company's earnings releases and outlook updates of the last two years. Each forecast is shown with the sentence or table row it was read from; what a release does not state in figures is not shown.
Latest guidance given with Q3 FY2026 results, 6 Nov 2026
| Measure | Period | Guidance | As stated |
|---|
| EPS · GAAP | FY2026 | $16.84 | Reports 3Q26 earnings per share (EPS) of $1.33 on a GAAP basis, Adjusted loss per share of $0.70; reports year to date (YTD) 2026 EPS of $16.84 on a GAAP basis, $17.17 on an Adjusted basis |
|---|
| EPS · Adjusted | FY2026 | $17.17 | Reports 3Q26 earnings per share (EPS) of $1.33 on a GAAP basis, Adjusted loss per share of $0.70; reports year to date (YTD) 2026 EPS of $16.84 on a GAAP basis, $17.17 on an Adjusted basis |
|---|
Source: the company's earnings release.
Guidance against results last two years
The last range given before each period closed, how it moved between releases, and the figure then filed. A measure the company defines itself, or one not comparable with the filed figure, has no verdict.
| Measure | Period | Last guidance | Revisions | Delivered | Result |
|---|
| EPS · GAAP | FY2026 | $16.84 | Raised once | — | To come |
|---|
| EPS · Adjusted | FY2026 | $17.17 | Lowered once | — | To come |
|---|
HUM in the terminal
Guidance said on earnings calls, every revision charted, and guidance set against the analysts' consensus.